Keryx Biopharma (KERX) Stockholder BlackRock (BLK) Raises Stake to 10.5%
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Join SI Premium – FREE
Keryx Biopharma (Nasdaq: KERX) stockholder BlackRock (NYSE: BLK) raised its stake to 10.49 percent. The new stake was revealed in SEC filings. BlackRock is now the largest shareholder in Keryx, topping TA Capital's 6.5 percent interest.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoStar Group acquires Zonda for $800M, adding new home data
- Gossamer Bio raises up to $250M in private placement for PAH drug
- reAlpha completes $8.5M InstaMortgage acquisition
Create E-mail Alert Related Categories
Private EquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
